• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Orally active prostacyclin analogue in primary pulmonary hypertension.

作者信息

Okano Y, Yoshioka T, Shimouchi A, Satoh T, Kunieda T

出版信息

Lancet. 1997 May 10;349(9062):1365. doi: 10.1016/S0140-6736(97)24019-5.

DOI:10.1016/S0140-6736(97)24019-5
PMID:9149701
Abstract
摘要

相似文献

1
Orally active prostacyclin analogue in primary pulmonary hypertension.口服活性前列环素类似物治疗原发性肺动脉高压
Lancet. 1997 May 10;349(9062):1365. doi: 10.1016/S0140-6736(97)24019-5.
2
Beneficial hemodynamic effects of oral prostacyclin (PGI2) analogue, beraprost sodium, on a patient with primary pulmonary hypertension--a case report.口服前列环素（PGI2）类似物贝拉普罗钠对一名原发性肺动脉高压患者的有益血流动力学效应——病例报告
Angiology. 1998 Feb;49(2):161-4. doi: 10.1177/000331979804900210.
3
Hemodynamic and hormonal effects of beraprost sodium, an orally active prostacyclin analogue, in patients with secondary precapillary pulmonary hypertension.口服活性前列环素类似物贝拉前列素钠对继发性毛细血管前性肺动脉高压患者的血流动力学和激素影响。
Circ J. 2003 May;67(5):375-8. doi: 10.1253/circj.67.375.
4
Emerging therapies for pulmonary hypertension: striving for efficacy and safety.
J Am Coll Cardiol. 2003 Jun 18;41(12):2126-9. doi: 10.1016/s0735-1097(03)00468-6.
5
[Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].新型口服前列环素类似物贝拉普罗斯钠对重度肺动脉高压患者的短期和长期影响
J Cardiol. 1996 Apr;27(4):197-205.
6
[Therapy of severe pulmonary hypertension with prostacyclin and iloprost].
Dtsch Med Wochenschr. 2001 May 25;126(21):631-7. doi: 10.1055/s-2001-14422.
7
Short-term hemodynamic effect of a new oral PGI2 analogue, beraprost, in primary and secondary pulmonary hypertension.新型口服前列环素类似物贝拉普罗斯对原发性和继发性肺动脉高压的短期血流动力学影响
Am J Cardiol. 1996 Jul 15;78(2):244-7. doi: 10.1016/s0002-9149(96)90408-7.
8
Epoprostenol for primary pulmonary hypertension.依前列醇用于原发性肺动脉高压
Med Lett Drugs Ther. 1996 Feb 16;38(968):14-5.
9
Comparison of acute hemodynamic responses to prostacyclin with standard vasodilators in patients with primary pulmonary hypertension.原发性肺动脉高压患者中前列环素与标准血管扩张剂急性血流动力学反应的比较。
Chest. 1988 Mar;93(3 Suppl):179S. doi: 10.1378/chest.93.3_supplement.179s.
10
The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.前列环素对系统性硬化症继发肺动脉高压患者肺血流动力学的急性影响。
Arthritis Rheum. 1998 Mar;41(3):466-9. doi: 10.1002/1529-0131(199803)41:3<466::AID-ART13>3.0.CO;2-O.

引用本文的文献

1
Antiplatelet strategies: past, present, and future.抗血小板策略：过去、现在和未来。
J Thromb Haemost. 2023 Dec;21(12):3317-3328. doi: 10.1016/j.jtha.2023.09.013.
2
Clinical Outcomes and Treatment Options in Patients With Pulmonary Hypertension Who Received Pulmonary Hypertension-Specific Drugs　- Single-Center Case Series.接受肺动脉高压特异性药物治疗的肺动脉高压患者的临床结局及治疗选择——单中心病例系列
Circ Rep. 2019 Aug 28;1(9):389-395. doi: 10.1253/circrep.CR-19-0059.
3
Goal-Oriented Sequential Combination Therapy Evaluated Using Cardiopulmonary Exercise Parameters for the Treatment of Newly Diagnosed Pulmonary Arterial Hypertension　- Goal-Oriented Therapy Evaluated by Cardiopulmonary Exercise Testing for Pulmonary Arterial Hypertension (GOOD EYE).
使用心肺运动参数评估的目标导向序贯联合疗法治疗新诊断的肺动脉高压——通过心肺运动试验评估的肺动脉高压目标导向疗法（GOOD EYE）
Circ Rep. 2019 Jun 2;1(7):303-311. doi: 10.1253/circrep.CR-19-0047.
4
Medium-term health-related quality of life in patients with pulmonary arterial hypertension treated with goal-oriented sequential combination therapy based on exercise capacity.基于运动能力的目标导向序贯联合治疗对肺动脉高压患者的中期健康相关生活质量的影响。
Health Qual Life Outcomes. 2019 Jun 14;17(1):103. doi: 10.1186/s12955-019-1178-x.
5
What Is the Role of Oral Prostacyclin Pathway Medications in Pulmonary Arterial Hypertension Management?口服前列环素通路药物在肺动脉高压管理中的作用是什么？
Curr Hypertens Rep. 2017 Oct 25;19(12):97. doi: 10.1007/s11906-017-0796-0.
6
Circulatory power and ventilatory power over time under goal-oriented sequential combination therapy for pulmonary arterial hypertension.肺动脉高压目标导向序贯联合治疗过程中循环功率和通气功率随时间的变化
Pulm Circ. 2017 Apr-Jun;7(2):448-454. doi: 10.1177/2045893217703954. Epub 2017 Mar 21.
7
Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.除一氧化氮外的新生儿肺动脉高压的药物治疗策略。
Semin Perinatol. 2016 Apr;40(3):160-73. doi: 10.1053/j.semperi.2015.12.004. Epub 2016 Jan 14.
8
Prostaglandin I2 IP Receptor Agonist, Beraprost, Prevents Transient Global Cerebral Ischemia Induced Hippocampal CA1 Injury in Aging Mice.前列环素 I2 IP 受体激动剂贝拉普罗斯可预防老龄小鼠短暂性全脑缺血诱导的海马 CA1 区损伤。
J Neurol Disord. 2014;2. doi: 10.4172/2329-6895.1000174.
9
Beraprost sodium attenuates cigarette smoke extract-induced apoptosis in vascular endothelial cells.贝前列素钠可减轻香烟烟雾提取物诱导的血管内皮细胞凋亡。
Mol Biol Rep. 2012 Dec;39(12):10447-57. doi: 10.1007/s11033-012-1924-1. Epub 2012 Oct 11.
10
Vascular effects of prostacyclin: does activation of PPARδ play a role?前列环素的血管作用：过氧化物酶体增殖物激活受体 δ 的激活是否起作用？
Trends Pharmacol Sci. 2012 Oct;33(10):559-64. doi: 10.1016/j.tips.2012.05.005. Epub 2012 Jun 23.